
Microsoft server hack hit about 100 victims, researchers say
WASHINGTON/LONDON — A sweeping cyber espionage operation targeting Microsoft server software compromised about 100 different organizations as of the weekend, two of the organizations that helped uncover the campaign said on Monday.
Microsoft on Saturday issued an alert about 'active attacks' on self-managed SharePoint servers, which are widely used by government agencies and businesses to share documents within organizations.
Dubbed a 'zero-day' because it leverages a previously undisclosed digital weakness, the hacks allow spies to penetrate vulnerable servers and potentially drop a backdoor to secure continuous access to victim organizations.
Vaisha Bernard, the chief hacker at Eye Security, a Netherlands-based cybersecurity firm, which discovered the hacking campaign targeting one of its clients on Friday, said that an internet scan carried out with the Shadowserver Foundation had uncovered nearly 100 victims altogether - and that was before the technique behind the hack was widely known.
'It's unambiguous,' Bernard said. 'Who knows what other adversaries have done since to place other backdoors.'
He declined to identify the affected organizations, saying that the relevant national authorities had been notified.
The Shadowserver Foundation confirmed the 100 figure and said that most of those affected were in the United States and Germany and that the victims included government organizations.
Another researcher said that, so far, the spying appeared to be the work of a single hacker or set of hackers.
'It's possible that this will quickly change,' said Rafe Pilling, director of Threat Intelligence at Sophos, a British cybersecurity firm.
Microsoft said it had 'provided security updates and encourages customers to install them,' a company spokesperson said in an emailed statement.
It was not clear who was behind the ongoing hack. The FBI said on Sunday it was aware of the attacks and was working closely with its federal and private-sector partners, but offered no other details. Britain's National Cyber Security Center said in a statement that it was aware of 'a limited number' of targets in the United Kingdom.
According to data from Shodan, a search engine that helps to identify internet-linked equipment, over 8,000 servers online could theoretically have already been compromised by hackers.
Those servers include major industrial firms, banks, auditors, healthcare companies, and several U.S. state-level and international government entities.
'The SharePoint incident appears to have created a broad level of compromise across a range of servers globally,' said Daniel Card of British cybersecurity consultancy, PwnDefend.
'Taking an assumed breach approach is wise, and it's also important to understand that just applying the patch isn't all that is required here.'
Reporting by James Pearson and Raphael Satter, Editing by Nick Zieminski and Marguerita Choy.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
11 minutes ago
- Globe and Mail
AstraZeneca's Latest Study: Evaluating Ceralasertib's Impact on Cancer Drug Pharmacokinetics
AstraZeneca ((AZN)), Parexel International ((PRXL)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. AstraZeneca, in collaboration with Parexel International, is conducting a Phase I clinical study titled 'A Phase I, Open-label, Fixed-sequence Study to Evaluate the Effect of Ceralasertib on Pharmacokinetics of Drug X, Drug Y and Drug Z in Participants With Advanced Solid Tumours.' The study aims to assess how ceralasertib affects the pharmacokinetics of three other drugs in patients with advanced solid tumors, potentially offering new insights into cancer treatment. The intervention involves administering ceralasertib, alongside Drugs X, Y, and Z. Ceralasertib is given twice daily over a week, with single doses of the other drugs administered on specific days to evaluate interactions. This open-label study follows a single-group assignment model with no masking, focusing on treatment as its primary purpose. It includes multiple visits and wash-out periods to ensure accurate results. The study began on May 21, 2025, with the latest update submitted on July 22, 2025. These dates are crucial for tracking the study's progress and ensuring transparency. For investors, this study could influence AstraZeneca's stock performance by potentially expanding its oncology portfolio. The collaboration with Parexel highlights a strategic partnership that could enhance research capabilities, impacting investor sentiment positively. Competitors in the oncology sector may also be closely monitoring these developments. The study is currently recruiting, with further details available on the ClinicalTrials portal.


Globe and Mail
14 minutes ago
- Globe and Mail
GE Vernova's Q2 Electrifies Stock, What's Next For This Top Name?
If GE Vernova's (NYSE: GEV) latest earnings results are any indication, General Electric's corporate restructuring continues to look like a stroke of genius. On July 23, the energy equipment spin-out saw shares soar over 14% after reporting Q2 financials. As of the July 23 close, GE Vernova has provided a total return of nearly 92% in 2025. This makes it the second-best performing stock in the S&P 500 Index, behind only Palantir Technologies (NASDAQ: PLTR). Let's break down GE Vernova's Q2, which validates the bullish sentiment on the stock. Ultimately, we'll aim to answer whether investors should continue betting that the stock's huge run will continue or if it is time to take profits and look for opportunities elsewhere. GEV's Q2: This Energy Enabler Is Firing on All Cylinders In Q2, sales came in at $9.1 billion, equating to a growth rate of 11%. This figure was approximately $328 million higher than Wall Street analysts anticipated. Just as important were the increases in the company's orders and backlog, as these are strong indicators of future revenue. Orders rose by 4% to $12.4 billion, 1.4 times higher than the company's revenue in Q2. Meanwhile, GE Vernova's backlog grew 11.4% to $129 billion, 3.5 times higher than the company's expected revenue in 2025. These figures are positive signs for investors in the near and long term. Right now, sales are outpacing expectations. Orders remain substantially higher than revenues, indicating that revenue growth can continue at this pace in the near term. The company's backlog indicates that long-term revenue potential is increasing slightly faster than current revenue. This suggests that GE Vernova can maintain or even accelerate its revenue growth in the coming years. Beating sales expectations and margin improvements helped GE Vernova post earnings per share of $1.86, surpassing estimates of $1.63. Additionally, the firm increased the midpoint of its free cash flow guidance by $1 billion to $3.25 billion. This might be the most encouraging sign of all for investors. Bringing in more cash than it spends is the ultimate goal of any business, and GE Vernova is making robust progress. AI Energy Needs Are Driving Huge Wins for GEV's Natural Gas Solutions Diving further into the company's report helps explain what is driving GE Vernova's incredible success. The company's Power segment is by far its largest, accounting for around 53% of total revenue last quarter. In this segment, the company sells natural gas turbines and provides servicing. Power also offers nuclear, hydroelectric, and steam power equipment and services. Orders in Power rose dramatically by 44% last quarter. Natural gas orders nearly tripled versus Q2 2024, driving this. Utility companies must scale up their electricity generation capacity to keep up with surging demand due to artificial intelligence (AI). AI data centers need energy that is both reliable and clean. This is why so many hyperscale data center companies have signed agreements for nuclear energy. However, the availability of nuclear sites is dropping, and new sites can take a decade to build. Thus, reliable and relatively clean natural gas is a logical alternative for scaling up energy capacity. Given its leadership in natural gas turbines, GE Vernova is an ideal company for meeting the demand for AI energy here and now. GE Vernova is also working to design and build nuclear small modular reactors (SMRs). SMRs help get around the long construction times of large reactors but are still in the developmental phase. This positions the company to meet the longer-term interests of hyperscalers. Additionally, GE Vernova's scale likely gives it a competitive advantage over smaller SMR developers. GEV: Valuation Is Lofty, But So Are Its Long-Term Opportunities As of July 23, GE Vernova trades at a forward price-to-earnings (P/E) ratio of 80x. That number is likely to come down as analysts revise earnings estimates upward. However, it is still 60% above the firm's average forward P/E of 50x since April 2024. This suggests that shares could be highly overvalued. However, it's tough to argue with the company's long-term prospects, especially given the potential of its SMR business. At the same time, it's hard to say the stock's massive surge and ballooning forward P/E don't warrant taking some money off the table. Maintaining some exposure to this name while looking for cheaper opportunities elsewhere feels like a prudent balance for investors to strike. Where Should You Invest $1,000 Right Now? Before you make your next trade, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list. They believe these five stocks are the five best companies for investors to buy now...


Globe and Mail
an hour ago
- Globe and Mail
New Buy Rating for SAP SE (0NW4), the Technology Giant
In a report released today, Sven Merkt from Barclays maintained a Buy rating on SAP SE, with a price target of €275.00. The company's shares closed yesterday at €245.83. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Merkt is a 3-star analyst with an average return of 2.2% and a 53.42% success rate. Merkt covers the Technology sector, focusing on stocks such as Temenos, Sage Group plc, and Adyen. Currently, the analyst consensus on SAP SE is a Strong Buy with an average price target of €299.65, which is a 21.89% upside from current levels. In a report released on July 23, Deutsche Bank also maintained a Buy rating on the stock with a €310.00 price target. 0NW4 market cap is currently €287.2B and has a P/E ratio of 44.29. Based on the recent corporate insider activity of 60 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of 0NW4 in relation to earlier this year.